Signal from the log
Biolevate
30 M€ · Series A · France · Health software
Biolevate fait écrire par des agents logiciels les documents scientifiques et réglementaires des laboratoires, protocoles cliniques et dossiers d'autorisation. Chaque sortie reste rattachée aux documents qui la fondent, pour qu'un humain puisse la relire en environnement réglementé. La société a été fondée à Paris par d'anciens ingénieurs de Dataiku.
Verified
Announced on , logged by the watch of 22 September 2026.
- Operation
- Funding round
- Announced amount
- 30 M€
- Stage
- Series A
- Country
- France
- Sector
- Health software
What the log says
Editorial note, in French
Communiqué ouvert, montant relu et fonds nommés.
The investors
Led by RAISE France , Orange Ventures , with MSD Global Health Innovation Fund , Station F , EQT Ventures
Provenance
Logged on 22 September 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Verified The press release was opened: amount double checked, funds named. The article remains to be written.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.